CompletedNot Applicable

VR-Assisted Rehabilitation in Partial Supraspinatus Tears

Turkey (Türkiye)49 participantsStarted 2025-01-01

Plain-language summary

This randomized controlled trial aims to investigate the effects of virtual reality-assisted rehabilitation in patients with partial supraspinatus tendon tears. Virtual reality has emerged as a promising tool to enhance patient engagement and improve rehabilitation outcomes in musculoskeletal disorders; however, evidence in this patient population remains limited. Participants will be assigned to either a virtual reality-assisted rehabilitation group or a conventional rehabilitation group. Both groups will receive a structured physical therapy program, while the intervention group will additionally perform virtual reality-based exercises. The study will evaluate the potential benefits of virtual reality in improving clinical outcomes compared to conventional rehabilitation.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 18 and 65 years * Shoulder pain persisting for more than 4 weeks * Diagnosis of partial supraspinatus tendon tear confirmed by shoulder magnetic resonance imaging Exclusion Criteria: * Received physiotherapy treatment within the previous 6 months * Received shoulder injection within the previous 6 months * History of tendon repair surgery * Presence of communication or cognitive impairment * Vertigo or vestibular disorders, or other conditions causing balance instability * History of epilepsy or seizures * Sensitivity to light * Diagnosed psychiatric disorders (including anxiety disorders or claustrophobia) * Any additional orthopedic condition affecting the same shoulder * Pregnancy or breastfeeding * Neurological, vascular, or cardiac disorders that may restrict functional capacity

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Pain intensity measured by the Numeric Rating Scale (NRS)

Timeframe: Baseline and after 3 weeks of treatment

Trial details

NCT IDNCT07478835

SponsorHitit University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-20

View on ClinicalTrials.gov More Partial Supraspinatus Tear trials